EGFR and neoplasm: Using EGFR-directed, monovalent and biparatopic sdAb formats as examples, we performed an intensive preclinical characterization and compared the different derivatives in vitro and in vivo with regard to their cell binding, internalization and cytotoxicity as well as their pharmacokinetics, biodistribution and tumor accumulation.